 |
|
Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use—Invited Commentary
Elizabeth A. Jackson, MD, MPH
Arch Intern Med. 2008;168(5):492.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Of the estimated 1.2 million Americans expected to experience a coronary event in 2007, approximately half a million will experience recurrent cardiac events.1 Thus, improvements in secondary prevention efforts that lead to reductions in these numbers carry considerable public health implications. Current guidelines recommend that low-risk patients return for follow-up shortly after discharge,2-3 and some guidelines2 recommend that higher-risk patients return 2 weeks after discharge. In this issue of the Archives, Daugherty et al examined data from a multicenter registry of 1516 patients hospitalized for acute myocardial infarction (AMI). Patients who reported an outpatient visit with a primary care physician or cardiologist within 1 month of discharge were defined as having received early follow-up. The primary outcomes of interest were receipt of evidence-based medications that are beneficial in treating cardiac conditions (including aspirin, β-blockers, angiotensin-converting enzyme [ACE] inhibitors, and statins) in eligible patients at . . . [Full Text of this Article]
AUTHOR INFORMATION
RELATED ARTICLE
Association of Early Follow-up After Acute Myocardial Infarction With Higher Rates of Medication Use
Stacie L. Daugherty, P. Michael Ho, John A. Spertus, Philip G. Jones, Richard G. Bach, Harlan M. Krumholz, Eric D. Peterson, John S. Rumsfeld, and Frederick A. Masoudi
Arch Intern Med. 2008;168(5):485-491.
ABSTRACT
| FULL TEXT
|
